跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,733 条关于
“ALKS 7290”
全部
1,733
临床试验
1,196
药物
202
机构
10
资讯
325
22小时前
Alkermes' orexin 2 receptor agonist ALKS 7290 shows symptom reductions in Phase 1b ADHD trial
去年
Alkermes Presents Positive Phase 1b Data for ALKS 2680 in Narcolepsy Type 2 and Idiopathic Hypersomnia
去年
FDA Panel Approves Sage's Novel Antidepressant for Postnatal Depression, Rejects Alkermes' Treatment
去年
Hypersomnia Pipeline Shows Promise with 10+ Emerging Therapies in Development
6个月前
Hypersomnia Pipeline Advances with Novel Therapies from Avadel, Zevra, and Alkermes
2年前
Centessa's ORX750 Advances to Phase 2 for Narcolepsy and Idiopathic Hypersomnia After Promising Phase 1 Results
3个月前
SPDR S&P Pharmaceuticals ETF Outperforms Biotech Counterparts with Lower Costs and Stronger Returns
去年
IL-2 Inhibitor Pipeline Expands with 20+ Companies Developing 22+ Therapeutic Candidates
去年
Nemvaleukin Alfa Shows Durable Antitumor Activity in Advanced Melanoma and Renal Cell Carcinoma
13天前
Eppendorf launches refrigerated Centrifuge 5811 R with sustainable R290 cooling
第 1 页,共 33 页
上一页
下一页